000 01670nam a2200361 a 4500
001 ebr10680970
003 CaPaEBR
006 m u
007 cr cn|||||||||
008 100617s2010 nyu sb 001 0 eng d
010 _z 2010025918
020 _z9781617288517 (softcover)
020 _z9781617610332 (e-book)
040 _aCaPaEBR
_cCaPaEBR
035 _a(OCoLC)704284839
050 1 4 _aRC848.H425
_bF34 2010eb
082 0 4 _a616.3/623
_222
100 1 _aFahim, Magid A.
245 1 0 _aHepatitis C infection in dialysis
_h[electronic resource] /
_cMagid A. Fahim and David W. Johnson.
260 _aNew York :
_bNova Biomedical Books/Novinka,
_cc2010.
300 _a46 p.
490 1 _aNephrology research and clinical developments
504 _aIncludes bibliographical references (p. [35]-41) and index.
505 0 _aEpidemiology -- Risk factors for HCV acquisition in haemodialysis patients -- Prevention of HCV transmission in haemodialysis units -- Diagnosis, screening, and evaluation -- Hepatic pathology and complications -- Treatment and monitoring -- Outcomes.
533 _aElectronic reproduction.
_bPalo Alto, Calif. :
_cebrary,
_d2013.
_nAvailable via World Wide Web.
_nAccess may be limited to ebrary affiliated libraries.
650 0 _aHepatitis C.
650 0 _aHemodialysis
_xComplications.
655 7 _aElectronic books.
_2local
700 1 _aJohnson, David W.
_q(David Wayne),
_d1964-
710 2 _aebrary, Inc.
830 0 _aNephrology research and clinical developments series.
856 4 0 _uhttp://site.ebrary.com/lib/rucke/Doc?id=10680970
_zAn electronic book accessible through the World Wide Web; click to view
999 _c174201
_d174201